Clin2
NCT05569577Possibly a fitRecruiting

Extra hCG injections to help pregnancy in IHH

Luteal Phase DeficiencyLuteal Phase SupportIdiopathic Hypogonadotropic Hypogonadism

Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.

This trial studies whether adding extra hCG shots improves pregnancy outcomes for people diagnosed with IHH, a hormone-related cause of not starting periods. If you’re trying to get pregnant, it may help test whether this added treatment improves your chances.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
46 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You have a clinical diagnosis of IHH (not having periods starting, linked to low brain-pituitary hormone signals).
  • Your blood LH and FSH levels are low (both under 5 IU/L) or your results are considered normal for the study.
  • Your brain MRI shows no tumor or other organic problem in the hypothalamus/pituitary area.
  • You’re of childbearing age and you want to become pregnant.
  • You do NOT have premature ovarian insufficiency or premature ovarian failure.
  • Your amenorrhea is NOT due to a known problem in the hypothalamus or pituitary (like a lesion).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05080569Recruiting· Phase 4
Extra support after IUI for couples with unclear infertility

This study tests whether adding support in the period after ovulation (the “luteal phase”) helps people who are starting IUI (intrauterine insemination) because their infertility is unexplained. It’s designed to see if the added care improves chances when mild ovarian stimulation is used.

Utrecht
NCT07128394Recruiting
Extra LH hormone for better embryos in IVF with low LH

This trial tests whether giving extra luteinizing hormone (LH) can improve embryo quality in women with very low LH levels during IVF. It may help you if you have low LH and are using a specific type of fertility medication.

Nanjing, Jiangsu
NCT06150703Recruiting· Phase 3
Luteal phase support with GnRH agonist after egg retrieval trigger

This trial tests whether giving a medication called a GnRH agonist during the luteal phase (the time after egg retrieval) can help with IVF success. It is for people who are using a specific medication protocol (recombinant FSH with an antagonist) and have certain hormone levels.

Bondy
NCT06571214Not yet recruiting· Phase 4
Adding LH hormone in IVF for women 35-40

This trial tests whether adding a hormone (r-hLH) to standard ovarian stimulation medicine helps women aged 35 to 40 produce more eggs during IVF. It may be a good option if you have lower ovarian reserve and are starting your first or second IVF cycle.

Nanjing, Jiangsu
NCT06883890Not yet recruiting· Phase 2
Extended LH for IVF patients with low LH

This trial tests whether giving extra LH hormone during an IVF cycle can improve outcomes for women who naturally have low LH levels. It may help your eggs develop better.

NCT04719000Recruiting· Phase 4
Personalized LH addition during IVF to improve egg growth

This trial tests whether adding a personalized amount of “LH” during IVF hormone stimulation can help your ovaries respond better. It may be useful if you’ve had a weaker IVF response before and fit specific age and egg-quality markers.

Barcelona

Hear when a new Luteal Phase Deficiency trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.